About NeoCura

NeoCura is a high-tech enterprise that relies on AI technology to create an RNA technology platform and conduct R&D of innovative drugs. The company has built multi-omics big data acquisition platforms and multiple bioomics databases. It uses AI and bioinformatics technology to conduct in-depth drug target mining and fully automated drug design for innovative RNA technology platform upgrades and drug research. It has established leading R&D centers and production centers in Beijing, Shenzhen, and Guangzhou to support pipelines development, platform upgrades, and clinical demand.



AI

empowerment

Pipelines leadership

AI empowers RNA throughout the entire flow process, accelerating research and development of drugs and technology upgrades

A top-notch complementarity team, bringing together top experts from tumor immunology, RNA delivery, molecular engineering, artificial intelligence, and industrialization fields

Gather strength by integrating top resources in research, industry, and clinical fields at home and abroad to break through obstacles

Team

advantages

Resource integration

ABOUT US

More than 10 First-in-Class R&D pipelines focusing on mRNA tumor neoantigen vaccines , tumor microenvironment immuno-modulator, and virus vaccines

03

NeoCura   

02

NeoCura   

01

NeoCura   

R&D Pipelines

TM

TM

TM

mRNA Cancer Neoantigen Vaccines

Tumor Microenvironment Immune Regulator

Prophylactic Vaccine

Ag

IM

PV

Science Platforms

News

Scan code to follow us on WeChat

NeoCura Bio-Medical Technology Co., Ltd.

Beijing: Room C301, No. 29 Shengmingyuan Road, Life Science Park, Changping District, Beijing





Websitewww.neocura.com.cn

E-mailinfo@neocura.net

             bd@neocura.net

             pr@neocura.net

Tel+86 10 80766127




Guangzhou: 10/F, Block B, No. 388 Lianyun Road, Huangpu District, Guangzhou, China





Shenzhen: 12/F, Block B, Building 1, Yinxingzhijie Phase II, Longhua District, Shenzhen, China

Address:

  • Telephone

    • 010-80766127
  • ΢ɨһɨ

seo seo